BlueRock Therapeutics
Germany - BerlinBiotechnology
Focus: BlueRock Therapeutics is a Berlin-based biotech company specializing in stem cell therapies, with a focused pipeline in cell therapy for neurodegenerative and retinal diseases. The company operates as a pre-revenue or early-stage biotech entity with limited disclosed financial scale.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About BlueRock Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow BlueRock Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Noninterventional Study Evaluating Parkinson's Disease Diary Use
Parkinson's DiseaseClinical Trials (1)
NCT05363046Noninterventional Study Evaluating Parkinson's Disease Diary Use
N/AHelp build intelligence for BlueRock Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.